dexamethasone + loteprednol etabonate

Dexamethasone + loteprednol etabonate is a combination of two synthetic corticosteroids formulated for ophthalmic use. Both agents act as anti-inflammatory drugs by suppressing the immune response and reducing inflammation, pain, and swelling in ocular tissues. Dexamethasone is a potent glucocorticoid with well-established efficacy in controlling ocular inflammation but carries a higher risk of increasing intraocular pressure (IOP). Loteprednol etabonate is an ester corticosteroid designed to be rapidly deactivated after exerting its local effect, resulting in lower systemic absorption and reduced risk of IOP elevation compared to traditional steroids like dexamethasone. This combination would theoretically provide robust anti-inflammatory action while potentially minimizing steroid-induced side effects such as increased IOP or cataract formation. Both drugs are primarily indicated for the treatment of post-operative eye inflammation, allergic conjunctivitis, uveitis, and other inflammatory conditions affecting the anterior segment of the eye[2][4][6].